Profile
Elena Traistaru is currently the Chief Financial Officer at Emerald Health Bioceuticals, Inc. and the Corporate Controller at Emerald Health Usa, Inc. She previously worked as the Controller at Enigma Diagnostics Ltd. from 2010 to 2017, the Chief Financial Officer at Skye Bioscience, Inc. in 2020, and the President & Chief Financial Officer at Et Accounting Consulting from 2017 to 2018.
Ms. Traistaru obtained her undergraduate degree from Bucharest Academy of Economic Studies.
Elena Traistaru active positions
| Companies | Position | Start |
|---|---|---|
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Director of Finance/CFO | 2019-09-30 |
Emerald Health Usa, Inc. | Comptroller/Controller/Auditor | 2018-10-31 |
Former positions of Elena Traistaru
| Companies | Position | End |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Director of Finance/CFO | 2020-09-24 |
Et Accounting Consulting | Chief Executive Officer | 2018-09-30 |
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings | Comptroller/Controller/Auditor | 2017-01-31 |
Training of Elena Traistaru
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings | Health Technology |
Bucharest Academy of Economic Studies
Bucharest Academy of Economic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Health Technology |
Emerald Health Usa, Inc. | |
Et Accounting Consulting |
- Stock Market
- Insiders
- Elena Traistaru
















